Raymond James & Associates »

Apellis Pharmaceuticals shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 19k 58.78
2023-12-31 $921k 15k 59.86
2023-09-30 $1.6M 42k 38.04
2023-06-30 $4.1M 46k 91.10
2023-03-31 $4.1M 62k 65.96
2022-12-31 $747k 14k 51.71
2022-09-30 $958k 14k 68.27
2022-06-30 $364k 8.0k 45.22
2022-03-31 $324k 6.4k 50.74
2021-12-31 $323k 6.8k 47.22
2021-09-30 $239k 7.3k 32.94
2021-06-30 $475k 7.5k 63.16
2021-03-31 $666k 16k 42.92
2020-12-31 $353k 6.2k 57.14
2020-06-30 $210k 6.4k 32.70
2020-03-31 $219k 8.2k 26.79